OrthoPediatrics (KIDS) announced a preliminary 4Q17 revenue range of US $11.5MM to $11.7MM, up 22% to 24% vs. 4Q16, and full-year revenue in the range of $45.4MM to $45.6MM, +22% vs. 2016.
Sequentially, this preliminary revenue is a -6% dip vs. 3Q17, which was its first quarter reporting as a publicly-traded company. You can review KIDS’ revenue from 2011 through 2016 in our 3Q17 revenue coverage.
Final revenue results will be announced in late 1Q18.
OrthoPediatrics (KIDS) announced a preliminary 4Q17 revenue range of US $11.5MM to $11.7MM, up 22% to 24% vs. 4Q16, and full-year revenue in the range of $45.4MM to $45.6MM, +22% vs. 2016.
Sequentially, this preliminary revenue is a -6% dip vs. 3Q17, which was its first quarter reporting as a publicly-traded company. You can review KIDS'...
OrthoPediatrics (KIDS) announced a preliminary 4Q17 revenue range of US $11.5MM to $11.7MM, up 22% to 24% vs. 4Q16, and full-year revenue in the range of $45.4MM to $45.6MM, +22% vs. 2016.
Sequentially, this preliminary revenue is a -6% dip vs. 3Q17, which was its first quarter reporting as a publicly-traded company. You can review KIDS’ revenue from 2011 through 2016 in our 3Q17 revenue coverage.
Final revenue results will be announced in late 1Q18.
Copy to clipboard 
